JP2012521377A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521377A5 JP2012521377A5 JP2012501179A JP2012501179A JP2012521377A5 JP 2012521377 A5 JP2012521377 A5 JP 2012521377A5 JP 2012501179 A JP2012501179 A JP 2012501179A JP 2012501179 A JP2012501179 A JP 2012501179A JP 2012521377 A5 JP2012521377 A5 JP 2012521377A5
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- mixture
- azaspiro
- pyridin
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- BQGSQOJLJNORRH-AWEZNQCLSA-N (3s)-3-[(2-chlorobenzoyl)amino]-2,3-dihydro-1h-indene-4-carboxylic acid Chemical compound N([C@H]1CCC=2C=CC=C(C1=2)C(=O)O)C(=O)C1=CC=CC=C1Cl BQGSQOJLJNORRH-AWEZNQCLSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YPDBTGIIQHAPMI-UHFFFAOYSA-N 2-azaspiro[4.5]decan-8-ol Chemical compound C1NCCC11CCC(CC1)O YPDBTGIIQHAPMI-UHFFFAOYSA-N 0.000 description 1
- -1 2-benzyl-8- (pyridin-4-yl) -2-azaspiro [4.5] dec-7-ene pyridine Chemical compound 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- REYMPXXKOPTETK-UHFFFAOYSA-N 8-pyridin-4-yl-2-azaspiro[4.5]decane Chemical compound C1NCCC21CCC(C=1C=CN=CC=1)CC2 REYMPXXKOPTETK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- 241001274216 Naso Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09004235.9 | 2009-03-25 | ||
| EP09004235 | 2009-03-25 | ||
| EP09011708.6 | 2009-09-14 | ||
| EP09011708 | 2009-09-14 | ||
| PCT/EP2010/001804 WO2010108651A1 (en) | 2009-03-25 | 2010-03-23 | Substituted spiro-amide compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012521377A JP2012521377A (ja) | 2012-09-13 |
| JP2012521377A5 true JP2012521377A5 (enExample) | 2013-02-14 |
Family
ID=42224836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012501179A Pending JP2012521377A (ja) | 2009-03-25 | 2010-03-23 | 置換スピロアミド化合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8455475B2 (enExample) |
| EP (1) | EP2411381A1 (enExample) |
| JP (1) | JP2012521377A (enExample) |
| KR (1) | KR20110137377A (enExample) |
| CN (1) | CN102365276A (enExample) |
| AR (1) | AR076148A1 (enExample) |
| AU (1) | AU2010227802A1 (enExample) |
| BR (1) | BRPI1013614A2 (enExample) |
| CA (1) | CA2756532A1 (enExample) |
| CO (1) | CO6430424A2 (enExample) |
| EC (1) | ECSP11011390A (enExample) |
| IL (1) | IL215267A0 (enExample) |
| MX (1) | MX2011010068A (enExample) |
| NZ (1) | NZ595293A (enExample) |
| PE (1) | PE20120833A1 (enExample) |
| RU (1) | RU2011142618A (enExample) |
| TW (1) | TW201038572A (enExample) |
| WO (1) | WO2010108651A1 (enExample) |
| ZA (1) | ZA201107772B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2422718T3 (es) | 2009-04-02 | 2013-09-13 | Merck Patent Gmbh | Derivados de piperidina y piperazina como inhibidores de la autotaxina |
| ME02330B (me) * | 2010-03-19 | 2016-06-20 | Pfizer | Derivati 2,3-dihidro-1h-inden-1-il-2,7-diazaspir0[3.6]nonana i njihova upotreba kao antagonista ili inverznih agonista grelinskog receptora |
| US8809552B2 (en) * | 2011-11-01 | 2014-08-19 | Hoffmann-La Roche Inc. | Azetidine compounds, compositions and methods of use |
| SI2861566T1 (sl) | 2012-06-13 | 2017-03-31 | F. Hoffmann-La Roche Ag | Novi diazaspirocikloalkan in azaspirocikloalkan |
| DK2900669T3 (da) | 2012-09-25 | 2019-11-04 | Hoffmann La Roche | Hexahydropyrrolo[3,4-C]pyrrolderivater og relaterede forbindelser som autotaxin (ATX)-inhibitorer og som inhibitorer af lysophosphatidsyre (LPA)-produktion til behandling af f.eks. nyresygdomme |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| MX377396B (es) | 2013-09-12 | 2025-03-10 | Janssen Biopharma Inc | Compuestos de azapiridona y usos de los mismos. |
| JP6496730B2 (ja) | 2013-11-26 | 2019-04-03 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 新規なオクタヒドロ−シクロブタ［１，２−ｃ；３，４−ｃ’］ジピロール−２−イル |
| AU2015238541B2 (en) | 2014-03-26 | 2019-09-19 | F. Hoffmann-La Roche Ag | Condensed [1,4]diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors |
| CN106103446B (zh) | 2014-03-26 | 2019-07-30 | 豪夫迈·罗氏有限公司 | 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物 |
| JP6509321B2 (ja) * | 2014-07-15 | 2019-05-08 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 置換アザスピロ（４．５）デカン誘導体 |
| EP3268368A4 (en) | 2015-03-11 | 2018-11-14 | Alios Biopharma, Inc. | Aza-pyridone compounds and uses thereof |
| CN106008503B (zh) * | 2015-03-31 | 2020-09-01 | 齐鲁制药有限公司 | 螺环芳基砜作为蛋白激酶抑制剂 |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| KR20180043837A (ko) | 2015-09-04 | 2018-04-30 | 에프. 호프만-라 로슈 아게 | 페녹시메틸 유도체 |
| EP3353178B1 (en) | 2015-09-24 | 2021-07-14 | F. Hoffmann-La Roche AG | Bicyclic compounds as dual atx/ca inhibitors |
| MX2018001890A (es) | 2015-09-24 | 2018-06-20 | Hoffmann La Roche | Compuestos biciclicos como inhibidores de autotaxina (atx). |
| EP3353181B1 (en) | 2015-09-24 | 2021-08-11 | F. Hoffmann-La Roche AG | Bicyclic compounds as dual atx/ca inhibitors |
| RU2018114289A (ru) | 2015-09-24 | 2019-10-24 | Ф. Хоффманн-Ля Рош Аг | Бициклические соединения в качестве ингибиторов аутотаксина (atx) |
| WO2017072341A1 (en) | 2015-10-30 | 2017-05-04 | F. Hoffmann-La Roche Ag | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| MX2018007703A (es) * | 2015-12-22 | 2018-11-09 | Vitae Pharmaceuticals Inc | Inhibidores de la interaccion de menina-linaje leucemico mixto. |
| EA034898B1 (ru) | 2016-01-13 | 2020-04-03 | Грюненталь Гмбх | Производные 8-амино-2-оксо-1,3-диазаспиро[4,5]декана |
| HUE049134T2 (hu) | 2016-01-13 | 2020-08-28 | Gruenenthal Gmbh | 3-(karboximetil)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-dekán származékok |
| LT3402781T (lt) | 2016-01-13 | 2020-06-10 | Grünenthal GmbH | 3-((hetero)aril)-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekano dariniai |
| FI3429591T3 (fi) | 2016-03-16 | 2023-06-15 | Kura Oncology Inc | Substituoituja tieno[2,3-d]pyrimidiinijohdannaisia meniini-mll:n estäjinä ja käyttömenetelmiä |
| WO2018023029A1 (en) * | 2016-07-28 | 2018-02-01 | Mayo Foundation For Medical Education And Research | Small molecule activators of parkin enzyme function |
| EP3366683A1 (en) | 2017-02-28 | 2018-08-29 | Acousia Therapeutics GmbH | Cyclic amides, acteamides and ureas useful as potassium channel openers |
| JP7090099B2 (ja) | 2017-03-16 | 2022-06-23 | エフ．ホフマン－ラ ロシュ アーゲー | Ａｔｘインヒビターとしての新規二環式化合物 |
| CR20190423A (es) | 2017-03-16 | 2019-11-01 | Hoffmann La Roche | Nuevos compuestos biciclícos como inhibidores dobles de atx/ca |
| WO2019060365A1 (en) | 2017-09-20 | 2019-03-28 | Kura Oncology, Inc. | SUBSTITUTED MÉNINE-MLL INHIBITORS AND METHODS OF USE |
| WO2019200114A1 (en) * | 2018-04-12 | 2019-10-17 | Arbutus Biopharma Corporation | Methods for preparing substituted dihydroindene-4-carboxamide compounds |
| CN111434664A (zh) * | 2019-01-13 | 2020-07-21 | 西南大学 | 亚胺螺环哌啶类化合物的合成及应用 |
| WO2022165513A1 (en) | 2021-01-29 | 2022-08-04 | Cedilla Therapeutics, Inc. | Cdk2 inhibitors and methods of using the same |
| CN117561058A (zh) | 2021-06-26 | 2024-02-13 | 塞迪拉治疗股份有限公司 | Cdk2抑制剂及其使用方法 |
| CN113976072B (zh) * | 2021-11-10 | 2024-02-23 | 武汉青风凯默生物医药科技有限公司 | 一种4-甲酰基-n-cbz哌啶的制备装置及方法 |
| KR20250004702A (ko) | 2022-04-28 | 2025-01-08 | 가부시키가이샤 에스디에스 바이오텍크 | 할로알킬술폰아닐리드 화합물 및 그것들을 함유하는 제초제 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1109544A4 (en) * | 1998-09-01 | 2004-10-27 | Bristol Myers Squibb Co | POTASSIUM CHANNEL INHIBITORS AND THEIR METHOD OF USE |
| AU1948601A (en) * | 1999-12-06 | 2001-06-12 | Euro-Celtique S.A. | Triazospiro compounds having nociceptin receptor affinity |
| EP1725236A4 (en) | 2004-03-11 | 2009-05-13 | Glaxo Group Ltd | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS |
| JP5136929B2 (ja) | 2004-03-24 | 2013-02-06 | アボット・ラボラトリーズ | 三環式ピラゾール系キナーゼ阻害薬 |
| CA2584307A1 (en) * | 2004-10-15 | 2006-06-15 | Bayer Pharmaceuticals Corporation | Indane amides with antiproliferative activity |
| WO2006055752A2 (en) * | 2004-11-18 | 2006-05-26 | Incyte Corporation | INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHODS OF USING THE SAME |
| US20070032475A1 (en) * | 2005-04-15 | 2007-02-08 | Ye Xiaocong M | Novel compounds useful for bradykinin B1 receptor antagonism |
| DE102005030051A1 (de) * | 2005-06-27 | 2006-12-28 | Grünenthal GmbH | Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln |
| CA2614963C (en) * | 2005-07-19 | 2014-10-07 | Merck & Co., Inc. | Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| WO2007101007A2 (en) | 2006-02-23 | 2007-09-07 | Neurogen Corporation | Aryl sulfonyl heterocycles |
| WO2007140383A2 (en) | 2006-05-30 | 2007-12-06 | Neurogen Corporation | Spirocyclic sulfonamides and related compounds |
| NZ575566A (en) | 2006-09-29 | 2011-05-27 | Gruenenthal Chemie | Substituted sulfonamide derivatives |
| EP2086935A1 (de) | 2006-10-16 | 2009-08-12 | Grünenthal GmbH | Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren |
-
2010
- 2010-03-19 TW TW099108105A patent/TW201038572A/zh unknown
- 2010-03-23 EP EP10711343A patent/EP2411381A1/en not_active Withdrawn
- 2010-03-23 WO PCT/EP2010/001804 patent/WO2010108651A1/en not_active Ceased
- 2010-03-23 PE PE2011001692A patent/PE20120833A1/es not_active Application Discontinuation
- 2010-03-23 BR BRPI1013614A patent/BRPI1013614A2/pt not_active IP Right Cessation
- 2010-03-23 AU AU2010227802A patent/AU2010227802A1/en not_active Abandoned
- 2010-03-23 MX MX2011010068A patent/MX2011010068A/es active IP Right Grant
- 2010-03-23 RU RU2011142618/04A patent/RU2011142618A/ru not_active Application Discontinuation
- 2010-03-23 KR KR1020117025143A patent/KR20110137377A/ko not_active Withdrawn
- 2010-03-23 NZ NZ595293A patent/NZ595293A/xx not_active IP Right Cessation
- 2010-03-23 CN CN2010800139828A patent/CN102365276A/zh active Pending
- 2010-03-23 JP JP2012501179A patent/JP2012521377A/ja active Pending
- 2010-03-23 CA CA2756532A patent/CA2756532A1/en not_active Abandoned
- 2010-03-24 US US12/730,597 patent/US8455475B2/en not_active Expired - Fee Related
- 2010-03-25 AR ARP100100948A patent/AR076148A1/es not_active Application Discontinuation
-
2011
- 2011-09-21 IL IL215267A patent/IL215267A0/en unknown
- 2011-09-22 CO CO11123935A patent/CO6430424A2/es not_active Application Discontinuation
- 2011-10-11 EC ECSP11011390 patent/ECSP11011390A/es unknown
- 2011-10-24 ZA ZA2011/07772A patent/ZA201107772B/en unknown
-
2013
- 2013-04-15 US US13/862,690 patent/US20130231327A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012521377A5 (enExample) | ||
| CN103582622B (zh) | 经由亚胺鎓盐制备双环化合物的方法 | |
| JP6574474B2 (ja) | キラルジペプチジルペプチダーゼ−ｉｖ阻害剤の製造方法 | |
| WO2021056811A1 (zh) | 亚胺盐衍生物、其制备方法及尼古丁的制备方法 | |
| AU2015229742A1 (en) | Clomiphene synthesis using a single solvent | |
| JP2016500657A5 (enExample) | ||
| CN104844491B (zh) | 一种二硫代氨基甲酸酯的合成方法 | |
| CN102675181B (zh) | 一种左乙拉西坦的制备方法 | |
| JP5485138B2 (ja) | エチニルチミジン化合物の精製方法 | |
| CN105037216A (zh) | 一种月桂酰精氨酸盐酸盐的制备方法 | |
| CN113121318B (zh) | 一种联/杂芳烃类化合物及其制备方法 | |
| CN104710346A (zh) | 一种合成顺式-1-苄基-3-甲氨基-4-甲基-哌啶的方法 | |
| CN109232562A (zh) | 一种7-氮杂吲哚-5-氯-6-羧酸的合成方法 | |
| CN106045995A (zh) | 一种5‑溴‑1H‑吡咯并[2,3‑b]吡啶的合成方法 | |
| CN101747343B (zh) | 一种舒巴坦匹酯的制备方法 | |
| CN104860864B (zh) | 2‑羰基‑5‑炔基吡咯化合物的合成方法 | |
| CN103588600A (zh) | 一种空气氛围中铜催化有机硼酸化合物脱除硼酸基的方法 | |
| CN105315288A (zh) | 一种制备四氢吡咯并吡嗪并异吲哚衍生物的方法 | |
| CN103880817B (zh) | 一种3-氯-5-(3’-N-Boc-吡咯基)吡啶的化学合成方法 | |
| CN104592178B (zh) | 一种脱氢枞酸内酯的制备方法 | |
| CN110105361B (zh) | 一种Evodiakine及其衍生物的制备方法 | |
| CN105503595B (zh) | 一种r型2‑甲基‑己‑4‑炔酸甲酯的制备方法 | |
| EP3162796B1 (en) | Method for producing 2-amino-6-methylnicotinic acid | |
| CN105237431A (zh) | 一种非那西汀的制备与结晶方法 | |
| CN107118210A (zh) | 一种3‑碘‑6‑（三氟甲基）咪唑并[1,2‑a]吡啶的制备工艺 |